Sulfocoumarins as dual inhibitors of human carbonic anhydrase isoforms IX/XII and of human thioredoxin reductase.
Antigens, Neoplasm
/ metabolism
Antineoplastic Agents
/ chemical synthesis
Carbonic Anhydrase IX
/ antagonists & inhibitors
Carbonic Anhydrases
/ metabolism
Cell Proliferation
/ drug effects
Cell Survival
/ drug effects
Coumarins
/ chemical synthesis
Dose-Response Relationship, Drug
Drug Screening Assays, Antitumor
Enzyme Inhibitors
/ chemical synthesis
Humans
Isoenzymes
/ antagonists & inhibitors
MCF-7 Cells
Molecular Structure
Structure-Activity Relationship
Thioredoxin-Disulfide Reductase
/ antagonists & inhibitors
Tumor Cells, Cultured
Anticancer agents
carbonic anhydrase inhibition
hypoxia
oxidative stress
thioredoxin reductase inhibition
Journal
Journal of enzyme inhibition and medicinal chemistry
ISSN: 1475-6374
Titre abrégé: J Enzyme Inhib Med Chem
Pays: England
ID NLM: 101150203
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
entrez:
14
1
2020
pubmed:
14
1
2020
medline:
7
3
2020
Statut:
ppublish
Résumé
The hypothesis that sulfocoumarin acting as inhibitors of human carbonic anhydrase (CA, EC 4.2.1.1) cancer-associated isoforms
Identifiants
pubmed: 31928252
doi: 10.1080/14756366.2020.1712596
pmc: PMC7006680
doi:
Substances chimiques
Antigens, Neoplasm
0
Antineoplastic Agents
0
Coumarins
0
Enzyme Inhibitors
0
Isoenzymes
0
Thioredoxin-Disulfide Reductase
EC 1.8.1.9
CA9 protein, human
EC 4.2.1.1
Carbonic Anhydrase IX
EC 4.2.1.1
Carbonic Anhydrases
EC 4.2.1.1
carbonic anhydrase XII
EC 4.2.1.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
506-510Références
Bioorg Med Chem Lett. 2014 Mar 1;24(5):1256-60
pubmed: 24518190
Chem Rev. 2012 Aug 8;112(8):4421-68
pubmed: 22607219
J Enzyme Inhib Med Chem. 2012 Dec;27(6):845-8
pubmed: 21999604
Bioorg Med Chem Lett. 2012 Jan 1;22(1):267-70
pubmed: 22137345
J Enzyme Inhib Med Chem. 2013 Apr;28(2):407-11
pubmed: 22145736
J Enzyme Inhib Med Chem. 2013 Apr;28(2):294-8
pubmed: 22380772
J Med Chem. 2013 Jan 10;56(1):293-300
pubmed: 23241068
Bioorg Med Chem. 2013 Mar 15;21(6):1539-43
pubmed: 22892213
J Biol Chem. 1971 Apr 25;246(8):2561-73
pubmed: 4994926
Metabolites. 2017 Sep 16;7(3):
pubmed: 28926956
J Enzyme Inhib Med Chem. 2013 Apr;28(2):283-8
pubmed: 22168126
J Am Chem Soc. 2009 Mar 4;131(8):3057-62
pubmed: 19206230
Curr Protein Pept Sci. 2014;15(6):621-46
pubmed: 24875642
J Med Chem. 2011 Dec 22;54(24):8271-7
pubmed: 22077347
Trends Pharmacol Sci. 2017 Sep;38(9):794-808
pubmed: 28648527
Methods Enzymol. 1999;300:226-39
pubmed: 9919525
Eur J Med Chem. 2019 Nov 1;181:111580
pubmed: 31400708
Semin Cancer Biol. 2006 Dec;16(6):420-6
pubmed: 17092741
Nat Rev Drug Discov. 2008 Feb;7(2):168-81
pubmed: 18167490
Anticancer Agents Med Chem. 2017;17(2):164-170
pubmed: 27804847
J Enzyme Inhib Med Chem. 2019 Dec;34(1):665-671
pubmed: 30746961
Bioorg Med Chem. 2014 Mar 1;22(5):1522-8
pubmed: 24513186
J Med Chem. 2010 Jan 14;53(1):335-44
pubmed: 19911821
Expert Opin Ther Pat. 2017 May;27(5):547-556
pubmed: 27977313
Genome Biol. 2005;6(6):221
pubmed: 15960811
Biochemistry. 1982 Dec 21;21(26):6628-33
pubmed: 7159551